New warning for EVERY surgery patient
It was supposed to be the BETTER and SAFER blood thinner.
Instead, the drug dabigatran turned out to be a concern... and it can be found routinely hanging out on lists of the most dangerous meds in the nation.
It needs to be reconsidered.
So, what's the mainstream doing?
It's trying to EXPAND the use of the drug, giving it to MILLIONS of new patients who never would have dreamed of taking a blood thinner!
And if you're going in for any common form of surgery anytime soon, your own docs might push YOU into taking this dangerous medication afterward.
They'll cite this new study, which certainly sounds like a big win for the drug.
It finds that patients who have major operations (NOT including heart procedures) do much better when they take dabigatran afterward.
Most importantly, the drug helped protect against a condition called myocardial injury, or MINS, which is when the stress of surgery takes such a toll on the body that the heart suffers damage.
That can trigger a heart attack or stroke... cause clots... and even lead to amputations.
And in 1 in 10 cases, patients who develop this complication die within 30 days.
Clearly, it's important to cut the risk, and the drug seemed to do just that in older patients who had operations ranging from knee surgery to abdominal aortic aneurysm repair.
In the 16 months after surgery, folks given the drug had a 28 percent lower risk of MINS and other serious complications, when compared to folks given a placebo.
Tempting, right? Doctors are already talking about making this drug a routine part of post-operative care.
Don't fall for it.
There's a HUGE flaw with this study... starting with the fact that it was only tested against a placebo.
Researchers didn't test any other blood thinner, and they didn't put it up against the proven natural therapies that can often deliver the same results (or better) without the risks.
Speaking of risks, the new study claims that there are hardly any at all.
I'm not buying it.
The Institute for Safe Medication Practices estimates that more than 6 percent of patients taking blood thinners will visit ERs for a major bleeding problem... and the organization specifically named dabigatran as one of the drugs in this class to keep an eye on.